Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov;39(11):2102-2109.
doi: 10.1002/mds.29938. Epub 2024 Sep 3.

IRF2BPL-Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent with DRPLA

Sunita Venkateswaran  1   2 , Jean Michaud  3 , Yoko Ito  1 , Michael Geraghty  1   4 , Evan C Lewis  5 , Benjamin Ellezam  6 , Kym M Boycott  1 , David A Dyment  1 , Kristin D Kernohan  1   4 ; Care4Rare Canada Consortium  1
Affiliations
Case Reports

IRF2BPL-Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent with DRPLA

Sunita Venkateswaran et al. Mov Disord. 2024 Nov.

Abstract

Background: Childhood neurodegenerative diseases often pose a challenge to clinicians to diagnose because of the degree of genetic heterogeneity and variable presentations. Here, we present a child with progressive neurodegeneration consisting of spasticity, dystonia, and ataxia in which postmortem pathological analysis led to the diagnosis of interferon regulatory factor 2 binding protein like (IRF2BPL)-related disorder.

Methods: Detailed postmortem gross and histological examination was conducted, and findings consistent with dentatorubral-pallidoluysian atrophy (DRPLA) and included polyglutamine (polyQ) inclusions. Follow up testing for the CAG repeat expansion at ATN1 was non-diagnostic.

Results: Subsequent exome sequencing reanalysis of the research exome identified a pathogenic de novo IRF2BPL variant. The IRF2BPL c.562C>T, p.(Arg188Ter) variant, distal to the polyQ repeat tract, results in variable mRNA levels depending on the cell type examined with decreased mRNA in the brain, as well as destabilization of the protein product and corresponding downstream molecular abnormalities in patient derived cells.

Conclusion: We provide the first detailed pathological description for IRF2BPL-related disorder, termed NEDAMSS (neurodevelopmental disorder with regression, abnormal movements, loss of speech and seizures; Mendelian Inheritance in Man, 618088) and evidence for the inclusion of this condition in the differential diagnosis of spastic-ataxic neurodegenerative conditions, reminiscent of DRPLA. Although the individuals with NEDAMSS do not carry an expansion, the polyQ repeat tract may play a role in the pathological inclusions that would represent a novel disease mechanism for polyQ repeats. © 2024 International Parkinson and Movement Disorder Society.

Keywords: DRPLA; IRF2BPL; NEDAMSS; dystonia; neurodegeneration; polyglutamine repeats; spastic‐ataxia.

PubMed Disclaimer

References

    1. Shademan B, Biray Avci C, Nikanfar M, Nourazarian A. Application of next‐generation sequencing in neurodegenerative diseases: opportunities and challenges. Neuromolecular Med 2021;23(2):225–235.
    1. Mastrangelo M. Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta Neurol Belg 2019;119(4):511–521.
    1. Matilla‐Dueñas A, Corral‐Juan M, Rodríguez‐Palmero Seuma A, Vilas D, Ispierto L, Morais S, et al. Rare Neurodegenerative Diseases: Clinical and Genetic Update. In: Posada de la Paz, M, Taruscio, D, Groft, S. eds. Rare Diseases Epidemiology: Update and Overview. Advances in Experimental Medicine and Biology, Vol 1031. Cham: Springer; 2017:443–496. https://doi.org/10.1007/978-3-319-67144-4_25.
    1. Bamshad MJ, Nickerson DA, Chong JX. Mendelian gene discovery: fast and furious with No end in sight. Am J Hum Genet 2019;105(3):448–455.
    1. Hartley T, Lemire G, Kernohan KD, Howley HE, Adams DR, Boycott KM. New diagnostic approaches for undiagnosed rare genetic diseases. Annu Rev Genomics Hum Genet 2020;21:351–372.

Publication types

LinkOut - more resources